News
A University of Pennsylvania biotechnology company that aims to treat autoimmune diseases by reengineering cells within the ...
22h
The Times of Israel on MSNZelig Eshhar, leading cancer researcher and immunologist, dies at 84Research by Weizmann Institute scientist and Israel Prize winner saved 'countless lives,' was basis for technology sold for ...
A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...
While data is promising, many questions remain about topics such as timing and doses in the treatment of hematologic malignancies.
During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...
A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...
2d
News Medical on MSNStudy unveils powerful strategy to rejuvenate effectiveness of CAR T cell therapy against glioblastomaA team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...
2d
News-Medical.Net on MSNLeukemia-on-a-chip offers breakthrough in personalized cancer treatmentA team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...
chimeric antigen receptor 1 Articles . CRISPR Could Fry All Cancer Using Newly Found T-Cell. January 27, 2020 by Kristina Panos 36 Comments . One of the human body’s greatest features is its ...
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $69.0, a high ...
To the Editor: Garfall et al. (Sept. 10 issue)1 describe an interesting case of a patient with multiple myeloma who was successfully treated with autologous stem-cell transplantation followed by in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results